XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Goodwill and Intangible Assets (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract] |
Summary of intangible assets by major asset class | The following sets forth the goodwill and intangible assets by major asset class:
|  |  | June 30, 2018 |  | December 31, 2017
| Useful Life (Yrs) | Gross |  | Accumulated Amortization |  | Net Book Value |  | Gross |  | Accumulated Amortization |  | Net Book Value
Indefinite lived: |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill(a) |  |  | $ | 10,513,371 |  |  | $ | — |  |  | $ | 10,513,371 |  |  | $ | 10,513,371 |  |  | $ | — |  |  | $ | 10,513,371 |
Definite lived: |  |  |  |  |  |  |  |  |  |  |  |  |
Patents | 8 – 17 |  | 5,802,528 |  |  | (5,711,876 | ) |  | 90,652 |  |  | 5,802,528 |  |  | (5,681,673 | ) |  | 120,855 |
Licenses | 8 – 17 |  | 1,323,761 |  |  | (1,204,983 | ) |  | 118,778 |  |  | 1,323,761 |  |  | (1,190,609 | ) |  | 133,152 |
CELLECTRA®(b) | 5 – 11 |  | 8,106,270 |  |  | (7,465,649 | ) |  | 640,621 |  |  | 8,106,270 |  |  | (7,252,108 | ) |  | 854,162 |
GHRH(b) | 11 |  | 335,314 |  |  | (287,788 | ) |  | 47,526 |  |  | 335,314 |  |  | (271,948 | ) |  | 63,366 |
Bioject(c) | 2 – 15 |  | 5,100,000 |  |  | (1,735,556 | ) |  | 3,364,444 |  |  | 5,100,000 |  |  | (1,405,556 | ) |  | 3,694,444 |
Other(d) | 18 |  | 4,050,000 |  |  | (3,018,750 | ) |  | 1,031,250 |  |  | 4,050,000 |  |  | (2,906,250 | ) |  | 1,143,750 |
Total intangible assets |  |  | 24,717,873 |  |  | (19,424,602 | ) |  | 5,293,271 |  |  | 24,717,873 |  |  | (18,708,144 | ) |  | 6,009,729 |
Total goodwill and intangible assets |  |  | $ | 35,231,244 |  |  | $ | (19,424,602 | ) |  | $ | 15,806,642 |  |  | $ | 35,231,244 |  |  | $ | (18,708,144 | ) |  | $ | 16,523,100 |
(a) | Goodwill was recorded from the Inovio AS acquisition in January 2005, the acquisition of VGX in June 2009 and the acquisition of Bioject in April 2016 for $3.9 million, $6.2 million and $400,000, respectively.
(b) | CELLECTRA® and GHRH are developed technologies which were recorded from the acquisition of VGX.
(c) | Bioject intangible assets represent the estimated fair value of developed technology and intellectual property which were recorded from the Bioject asset acquisition.
(d) | Other intangible assets represent the estimated fair value of acquired intellectual property from the Inovio AS acquisition.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration